Serum programmed cell death protein 5 (pdcd5) levels is upregulated in liver diseases

Journal of Immunoassay and Immunochemistry

Volumn 34, Issue 3, 2013, Pages 294-304

  Chen, Yingyu ^a   Zou, Zhiqiang ^b   Xu, Ailing ^b   Liu, Youde ^b   Pan, Huan ^a   Jin, Lei ^c  

^a PEKING UNIVERSITY   (China)

^b Yantai Infectious Disease Hospital   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Biomarker; liver disease; programmed cell death protein 5; sandwich ELISA

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; MEMBRANE PROTEIN; PROGRAMMED CELL DEATH 5 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC ACTIVE HEPATITIS; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE COURSE; ENZYME IMMUNOASSAY; FEMALE; HEPATITIS B; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; UPREGULATION;

ADOLESCENT; ADULT; AGED; APOPTOSIS REGULATORY PROTEINS; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; UP-REGULATION;

EID: 84877949816     PISSN: 15321819     EISSN: 15324230     Source Type: Journal    
DOI: 10.1080/15321819.2012.731461     Document Type: Article

References (32)

1. Liu, H.; Wang, Y.; Zhang, Y.; Song, Q.; Di, C.; Chen, G.; Tang, J.; Ma, D. TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem. Biophys. Res. Commun. 1999, 254, 203-210.
2. Wang, Y.; Li, X.; Wang, L.; Ding, P.; Zhang, Y.; Han, W.; Ma, D. An alternative form of paraptosis-like cell death, triggered by TAJ=TROY and enhanced by PDCD5 overexpression. J. Cell. Sci. 2004, 117, 1525-1532.
3. Chen, L.; Wang, Y.; Ma, D.; Chen, Y. Short interfering RNA against the PDCD5 attenuates cell apoptosis and caspase-3 activity induced by bax overexpression. Apoptosis. 2006, 11, 101-111.
4. Chen, Y.; Sun, R.; Han, W.; Zhang, Y.; Song, Q.; Di, C.; Ma, D. Nuclear translocation of PDCD5 (TFAR19): An early signal for apoptosis? FEBS Lett. 2001, 509, 191-196.
5. Xu, L.; Chen, Y.; Song, Q.; Xu, D.; Wang, Y.; Ma, D. PDCD5 interacts with Tip60 and functions as a cooperator in acetyltransferase activity and DNA damage-induced apoptosis. Neoplasia. 2009, 11, 345-354.
6. Li, H.; Wang, Q.; Gao, F.; Zhu, F.; Wang, X.; Zhou, C.; Liu, C.; Chen, Y.; Ma, C.; Sun, W.; Zhang, L.Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas. Oncol Rep. 2008, 20,573-579.
7. Yang, Y.; Zhao, M.; Li, W.; Lu, Y.; Chen, Y.; Kang, B.; Lu, Y. Expression of programmed cell death 5 gene involves in regulation of apoptosis in gastric tumor cells. Apoptosis. 2006, 11, 993-1001.
8. Du, Y.; Xiong, L.; Lou, Y.; Tan, W.; Zheng, S. Reduced expression of programmed cell death 5 protein in tissue of human prostate cancer. Chin. Med. Sci. J. 2009, 24, 241-245.
9. Ruan, G.; Qin, Y.; Chen, S.; Li, J.; Ma, X.; Chang, Y.; Wang, Y.; Fu, J.; Liu, Y. Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia. Leuk. Res. 2006, 30, 1159-1165.
10. Spinola, M.; Meyer, P.; Kammerer, S.; Falvella, F. S.; Boettger, M. B.; Hoyal, C. R.; Pignatiello, C.; Fischer, R.; Roth, R. B.; Pastorino, U.; Haeussinger, K.; Nelson, M. R.; Dierkesmann, R.; Dragani, T. A.; Braun, A. Association of the PDCD5 locus with lung cancer risk and prognosis in smokers. J. Clin. Oncol. 2006, 24, 1672-1678.
11. Zhang, X.; Wang, X.; Song, X.; Wei, Z.; Zhou, C.; Zhu, F.; Wang, Q.; Ma, C.; Zhang, L. Clinical and prognostic significance of lost or decreased PDCD5 expression in human epithelial ovarian carcinomas. Oncol. Rep. 2011, 25, 353-358.
12. Chen, C.; Zhou, H.; Xu, L.; Liu, X.; Liu, Z.; Ma, D.; Chen, Y.; Ma, Q. Prognostic significance of downregulated expression of programmed cell death 5 in chondrosarcoma. J. Surg. Oncol. 2010, 102, 838-843.
13. Wang, Y.; Li, D.; Fan, H.; Tian, L.; Zhong, Y.; Zhang, Y.; Yuan, L.; Jin, C.; Yin, C.; Ma, D. Cellular uptake of exogenous human PDCD5 protein. J. Biol. Chem. 2006, 281, 24803-24817.
14. Chen, C.; Zhou, H.; Xu, L.; Xu, D.; Wang, Y.; Zhang, Y.; Liu, X.; Liu, Z.; Ma, D.; Ma, Q.; Chen, Y. Recombinant human PDCD5 sensitizes chondrosarcomas to cisplatin chemotherapy in vitro and in vivo. Apoptosis. 2010, 15, 805-813.
15. Shi, L.; Song, Q.; Zhang, Y.; Lou, Y.; Wang, Y.; Tian, L.; Zheng, Y.; Ma, D.; Ke, X.; Wang, Y. Potent antitumor activities of recombinant human PDCD5 protein in combination with chemotherapy drugs in K562 cells. Biochem. Biophys. Res. Commun. 2010, 396, 224-230.
16. Wang, Y.; Song, Q.; Zhang, Y. M.; Ma, D. L.; Wang, Y.; Ke, X. Recombinant human PDCD5 protein enhances chemosensitivities of hematologic malignancies. Chin. Sci. Bull. 2009, 54, 3981-3989.
17. Cheng, A.; Lou, S.; Zhou, H.; Wang, Y.; Ma, D. Expression of PDCD5, a novel apoptosis related protein, in human osteoarthritic cartilage. Acta Pharmacol. Sin. 2004, 25, 685-690.
18. Qin, H.; Chen, Y.; Liu, Z.; Hao, Y.; Wang, W. Expression of apoptosis-related protein TFAR19 in human lens epithelial cells from senile cataract patients. Chin. Ophthal. Res. 2002, 20, 514-516.
19. Sun, C.; Qiao, J.; Hu, Z.; Zhang, T.; Chen, Y. Expression of novel apoptosis-related protein PDCD5 in granulosa cells of polysystic ovary syndrome. Beijing Da Xue Xue Bao. 2005, 37, 476-479.
20. Wang, N.; Lu, H.; Guan, Z.; Sun, T.; Chen, Y.; Ruan, G.; Chen, Z.; Jiang, J.; Bai, C. Involvement of PDCD5 in the regulation of apoptosis in fibroblast-like synoviocytes of rheumatoid arthritis. Apoptosis 2007, 12, 1433-1441.
21. He, Y.; Qi, H.; Wen, W.; Wang, H.; Zhu, T. Studies on the expression of apoptosis-related molecule PDCD5 in the skin lesions psoriasis. Chin. J. Dermaol. 2004, 37, 215-217.
22. Wu, Y.; Nie, X.; Hu, D.; Lu, P.; Zhang, G.; Luo, L. The effect of carvedilol on apoptosis gene PDCD5 expression in chronic heart failure patients. Zhonghua Yi Xue Za Zhi. 2005, 85, 676-678.
23. Song, Q.; Di, C.; Zhong, Y.; Chen, X.; Li, S. A new gene in systemic lupus erythematosus pathogenesis. Chin. J. Rheumatol. 2002, 6, 328-330.
24. Bannai, H.; Nishikawa, Y.; Matsuo, T.; Kawase, O.; Watanabe, J.; Sugimoto, C.; Xuan, X. Programmed cell death 5 from toxoplasma gondii a secreted molecule that exerts a pro-apoptotic effect on host cells. Mol. Biochem. Parasitol. 2008, 159, 112-20.
25. Bannai, H.; Nishikawa, Y.; Ibrahim, H. M.;Yamada, K.; Kawase, O.; Watanabe, J.; Sugimoto, C.; Xuan, X. Overproduction of the pro-apoptotic molecule, programmed cell death 5, in toxoplasma gondii leads to increased apoptosis of host macrophages. J. Vet. Med. Sci. 2009, 71, 1183-1189.
26. Malhi, H.; Gores, G. J.; Lemasters, J. J. Apoptosis and necrosis in the liver: A tale of two deaths? Hepatology 2006, 43, S31-44.
27. Bantel, H.; Lugering, A.; Heidemann, J.; Volkmann, X.; Poremba, C.; Strassburg, C. P.; Manns, M. P.; Schulze-Osthoff, K. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury. Hepatology 2004, 40, 1078-1087.
28. Yao, H.; Xu, L.; Feng, Y.; Liu, D.; Chen, Y.; Wang, J. Structure-function correlation of human programmed cell death 5 protein. Arch. Biochem. Biophys. 2009, 486, 141-149.
29. Feldstein, A. E.; Canbay, A.; Angulo, P.; Taniai, M.; Burgart, L. J.; Lindor, K. D.; Gores, G. J. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003, 125, 437-443.
30. Feldstein, A. E.; Wieckowska, A.; Lopez, A. R.; Liu, Y.; Zein, N. N.; McCullough, A. J. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study. Hepatology 2009, 50, 1072-1078.
31. Scott, L. C.; Evans, T. R.; Cassidy, J.; Harden, S.; Paul, J.; Ullah, R.; O'Brien, V.; Brown, R. Cytokeratin 18 in plasma of patients with gastrointestinal adenocarcinoma as a biomarker of tumour response. Br. J. Cancer. 2009, 101, 410-417.
32. Linder, S.; Havelka, A. M.; Ueno, T.; Shoshan, M. C. Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarker. Cancer Lett. 2004, 214, 1-9.